Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
4-(3-((6-Carbamoyl-7-methoxyquinolin-4-yl)amino)-4-chlorophenoxy)-7-methoxyquinoline-6-carboxamide is an impurity of Lenvatinib, an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.